Active Stocks
Mon Dec 04 2023 15:47:26
  1. Power Grid Corporation Of India share price
  2. 212.9 1.21%
  1. Reliance Industries share price
  2. 2,421 1.15%
  1. State Bank Of India share price
  2. 594.65 3.99%
  1. HDFC Bank share price
  2. 1,609.05 3.44%
  1. Tata Steel share price
  2. 130.95 0.77%
Business News/ Markets / Stock Markets/  Fitch affirms Glenmark Pharmaceuticals rating at 'BB'; outlook stable
Back Back

Fitch affirms Glenmark Pharmaceuticals rating at 'BB'; outlook stable

Fitch Ratings affirms the Long-Term Issuer Default Rating (IDR) of 'BB' for Glenmark Pharmaceuticals Ltd.

Fitch Affirms Glenmark Pharmaceuticals at 'BB'; Outlook Stable (REUTERS)Premium
Fitch Affirms Glenmark Pharmaceuticals at 'BB'; Outlook Stable (REUTERS)

Fitch Ratings affirmed Glenmark Pharmaceuticals Ltd's Long-Term Issuer Default Rating (IDR) at 'BB' following the disclosure of its intention to sell a 75% ownership in its active pharmaceutical ingredient (API) business, held under subsidiary Glenmark Life Sciences Ltd. The outlook is 'Stable', according to the international credit rating agency release today.

"Exciting news! Mint is now on WhatsApp Channels 🚀 Subscribe today by clicking the link and stay updated with the latest financial insights!" Click here!

Glenmark Pharmaceuticals stated on September 21 that it would sell Nirma a 75% ownership in Glenmark Life Sciencesfor Rs615 per share, or a total value of Rs5,651.75 crore. Despite the drop in stakethe drugmaker will still hold a 7.84% stake in Glenmark Life Sciences.

Also Read: Glenmark Pharma to divest 75% stake in subsidiary Life Sciences unit to Nirma for 5,651 crore

"We believe Glenmark will use most of the net proceeds to repay debt. This and Glenmark's prudent approach to growth investments and shareholder returns will help it maintain negative net debt to EBITDA, which is significantly below the positive rating sensitivity level of 1.5x. Nonetheless, Glenmark's revenue scale and EBITDA margins, which are key metrics Fitch uses to measure the company's business profile, are unlikely to improve to levels commensurate with a higher rating," said Fitch in a release today.

Also Read: Nifty 50, Sensex drop over half a percent each: Five key reasons for the market fall - explained

Furthermore, despite significant margin compression, the credit rating agency stated that the expected sale is unlikely to have an impact on its evaluation of Glenmark's cost competitiveness and market position.

"The Stable Outlook reflects Glenmark's comfortable leverage headroom and our expectation of positive free cash flow before litigation settlement payments,"added Fitch.

Fitch Ratings in its release highlighted several key rating drivers, one of which was the stake sale, which is anticipated to be completed by March 2024 and will generate nearly 50 billion in proceeds net of taxes, exceeding net debt of 31.9 billion at the end of March 2023, excluding Glenmark Life Sciences Ltd.

Also Read: Maruti Suzuki share price falls over 2% on 2,160 crore draft income tax assessment notice

Given that Glenmark isn't planning on making sizable growth investments in the next years, Fitch believes that Glenmark can maintain a negative net debt position. The credit rating agency is not expecting a significant increase in shareholder returns.

"We forecast Glenmark's consolidated net debt to EBITDA, excluding Glenmark Life Sciences, to remain at around -1.0x, despite litigation settlement payments exceeding USD90 million in FY24-FY25.

Also Read: Sensex Today | Share Market Live Updates: Sensex tanks 400 pt; Bank stocks drag; Nestle shines

Glenmark Pharma share price today has been trading in red for the second consecutive session. Glenmark Pharma share price opened at 840.90 apiece on BSE . At 11:33 IST, Glenmark Pharma shares were trading at 817.50, down 3%.

Also Read: Glenmark Life Sciences share price falls 2% as Nirma readies to buy 75% stake in it

Milestone Alert!
Livemint tops charts as the fastest growing news website in the world 🌏 Click here to know more.

Catch all the Elections News, Business News, Market News, Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.
More Less
Updated: 04 Oct 2023, 11:45 AM IST
Next Story footLogo
Recommended For You

Get the best recommendations on Stocks, Mutual Funds and more based on your Risk profile!

Let’s get started
Switch to the Mint app for fast and personalized news - Get App